UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis

Frontiers in pharmacology, 2021-09, Vol.12, p.674748-674748

2021

Link zum Volltext

Verfügbarkeit prüfen

Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules

Frontiers in oncology, 2024-01, Vol.13, p.1239042-1239042

2024

Link zum Volltext

Verfügbarkeit prüfen

Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review

Journal of clinical medicine, 2022-02, Vol.11 (4), p.907

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk and Response-Adapted Treatment in Multiple Myeloma

Cancers, 2020-11, Vol.12 (12), p.3497

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy

Journal of clinical medicine, 2023-03, Vol.12 (7), p.2547

2023

Link zum Volltext

Verfügbarkeit prüfen

Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting

International journal of hematology, 2020-05, Vol.111 (5), p.614-618

2020

Link zum Volltext

Verfügbarkeit prüfen

Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia

Cell death & disease, 2022-06, Vol.13 (6), p.576-13, Article 576

2022

Link zum Volltext

Verfügbarkeit prüfen

The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia

Hemato, 2023-07, Vol.4 (3), p.207-226

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia

Journal of clinical medicine, 2024-01, Vol.13 (1), p.273

2024

Link zum Volltext

Verfügbarkeit prüfen

Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report

Diagnostics (Basel), 2022-08, Vol.12 (8), p.1910

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation

Diagnostics (Basel), 2022-10, Vol.12 (10), p.2493

2022

Link zum Volltext

Verfügbarkeit prüfen

Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation

Journal of clinical medicine, 2023-09, Vol.12 (18), p.6047

2023

Link zum Volltext

Verfügbarkeit prüfen

Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine

Vaccines (Basel), 2022-07, Vol.10 (7), p.1162

2022

Link zum Volltext

Verfügbarkeit prüfen

Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

Journal of clinical medicine, 2020-04, Vol.9 (4), p.1180

2020

Link zum Volltext

Verfügbarkeit prüfen

The Association between Major Depressive Disorder and Premature Death Risk in Hematologic and Solid Cancer: A Longitudinal Cohort Study

Journal of public health research, 2021-05, Vol.10 (3), p.jphr.2021.2247

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Clinical practice and epidemiology in mental health, 2021, Vol.17 (1), p.264-270

2021

Link zum Volltext

Verfügbarkeit prüfen

Systematic Review and Meta-Analysis of Health-Related Quality of Life in Patients with β-Thalassemia Underwent Hematopoietic Stem Cell Transplantation

Clinical practice and epidemiology in mental health, 2021-12, Vol.17 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib?

Blood, 2021-11, Vol.138 (Supplement 1), p.2573-2573

2021

Link zum Volltext

Verfügbarkeit prüfen

Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis

Annals of hematology, 2022-04, Vol.101 (4), p.929-931

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-term health-related quality of life in patients with β-thalassemia after unrelated hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2022-12, Vol.57 (12), p.1833-1836

2022

Link zum Volltext

Verfügbarkeit prüfen

Systematic Review and Meta-Analysis of Health-Related Quality of Life in Patients with β-Thalassemia that Underwent Hematopoietic Stem Cell Transplantation

Clinical practice and epidemiology in mental health, 2023, Vol.19 (Suppl-1), p.e174501792301031-e174501792301031

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura

Annals of hematology, 2024-07, Vol.103 (7), p.2523-2531

2024

Link zum Volltext

Verfügbarkeit prüfen

Model Order Reduction and Applications: Cetraro, Italy 2021

1st Edition 2023, 2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(85)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Hematology
(22)
Oncology
(22)
Humans
(20)
Chronic Myeloid Leukemia
(18)
Female
(14)
Leukemia
(14)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(13)
Male
(12)
Aged
(11)
Adult
(9)
Aged, 80 And Over
(9)
Medicine
(9)
Medicine & Public Health
(9)
Middle Aged
(9)
Patients
(9)
Cancer
(7)
General & Internal Medicine
(7)
Mathematics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis

Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules

Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review

Residual Peripheral Blood CD26 + Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission

Risk and Response-Adapted Treatment in Multiple Myeloma

Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy

Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting

Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia

The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia

Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study)

Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia

Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report

Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation

Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation

Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine

Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

The Association between Major Depressive Disorder and Premature Death Risk in Hematologic and Solid Cancer: A Longitudinal Cohort Study

Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Systematic Review and Meta-Analysis of Health-Related Quality of Life in Patients with β-Thalassemia Underwent Hematopoietic Stem Cell Transplantation

Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib?

Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis

Long-term health-related quality of life in patients with β-thalassemia after unrelated hematopoietic stem cell transplantation

Systematic Review and Meta-Analysis of Health-Related Quality of Life in Patients with β-Thalassemia that Underwent Hematopoietic Stem Cell Transplantation

Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura

Model Order Reduction and Applications: Cetraro, Italy 2021

Suchergebnisse filtern